Bespoke Extracts (BSPK) Net Equity Issued and Repurchased (2011 - 2022)
Bespoke Extracts (BSPK) reported Net Equity Issued and Repurchased of $1.0 for Q3 2022, down 100.0% sequentially from $147199.0 in Q2 2022.
Bespoke Extracts (BSPK) Net Equity Issued and Repurchased (2011 - 2022) Analysis & Trends
Bespoke Extracts (BSPK) has 9 years of Net Equity Issued and Repurchased data on file, last reported at $1.0 in Q3 2022.
- For the quarter ending Q3 2022, Net Equity Issued and Repurchased changed N/A year-over-year to $1.0; the trailing twelve-month figure through Dec 2022 stood at $344450.0 (changed N/A YoY), and the FY2022 full-year result was $344450.0, up 43.52% from the prior year.
- Net Equity Issued and Repurchased slipped to $1.0 in Q3 2022, from $147199.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $400000.0 in Q3 2021 to a low of $1.0 in Q3 2022.
- A 5-year average of $189995.0 and a median of $156099.5 in 2019 frame the typical range for Net Equity Issued and Repurchased.
- Across the five-year window, Net Equity Issued and Repurchased plunged 65.57% in 2019 and jumped 81.82% in 2020, its largest moves.
- Tracing BSPK's Net Equity Issued and Repurchased over 5 years: stood at $120000.0 in 2018, then slipped by 16.67% to $100000.0 in 2019, then surged by 200.0% to $300000.0 in 2020, then jumped by 33.33% to $400000.0 in 2021, then plunged by 100.0% to $1.0 in 2022.
- Business Quant data shows BSPK's Net Equity Issued and Repurchased at $1.0 in Q3 2022, $147199.0 in Q2 2022, and $197250.0 in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.00 |
| Sep 30, 2022 | 1.00 |
| Jun 30, 2022 | 147,199.00 |
| Jun 30, 2022 | 147,199.00 |
| Mar 31, 2022 | 197,250.00 |
| Mar 31, 2022 | 197,250.00 |
| Aug 31, 2021 | 400,000.00 |
| Aug 31, 2021 | 400,000.00 |
| Feb 29, 2020 | 300,000.00 |
| Feb 29, 2020 | 300,000.00 |
| Nov 30, 2019 | 100,000.00 |
| Nov 30, 2019 | 100,000.00 |
| May 31, 2019 | 120,500.00 |
| May 31, 2019 | 120,500.00 |
| Feb 28, 2019 | 165,000.00 |
| Feb 28, 2019 | 165,000.00 |
| Nov 30, 2018 | 120,000.00 |
| Nov 30, 2018 | 120,000.00 |
| May 31, 2018 | 350,000.00 |
| May 31, 2018 | 350,000.00 |